SAN FRANCISCO, March 11, 2026 /PRNewswire/ -- ClinCapture President and CEO Scott Weidley today announced a major expansion of artificial intelligence capabilities within the company's Captivate(R) ...

Glo-BNHL global trial opens sites in Netherlands and Austria to trial multiple new treatments for B-cell Non-Hodgkin Lymphoma ...

Understand the impact of IND delays on biotechnology companies and how they affect early-stage development and funding.

Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...

Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

A burdensome regulatory environment is pushing clinical trials overseas. Jacob Becraft is the co-founder and CEO of Strand Therapeutics.

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...

New research by Cleveland Clinic and Dyania Health demonstrates how a medically trained large language model system can accurately and efficiently screen electronic medical records (EMRs) to identify ...

“Designing treatments unique to individual patients has always been the promised goal of personalized medicine. After 25 years the FDA has, for the first time, outlined a framework to facilitate these ...

Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...